DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

FibroGen Q4 EPS $(1.12) Misses $(0.59) Estimate, Sales $7.974M Down From $108.054M YoY

FibroGen (NASDAQ:FGEN) reported quarterly losses of $(1.12) per share which missed the analyst consensus estimate of $(0.59) by 89.83 percent. This is a 586.96 percent decrease over earnings of $0.23 per share from the

Benzinga · 03/02/2020 21:03

FibroGen (NASDAQ:FGEN) reported quarterly losses of $(1.12) per share which missed the analyst consensus estimate of $(0.59) by 89.83 percent. This is a 586.96 percent decrease over earnings of $0.23 per share from the same period last year. The company reported $7.974 million in sales this quarter. This is a 92.62 percent decrease over sales of $108.054 million the same period last year.